MER Primary Care Conferences Internal Medicine for Primary Care Derm Endo Onc Vasc Jun 21-25, 2026

MER Primary Care Conferences Internal Medicine for Primary Care Derm Endo Onc Vasc Jun 21-25, 2026

+ Target Audience: internists, primary care physicians, dermatologists, endocrinologists, oncologists, and vascular medicine specialists

+ Information:

1. Overview

• Conference Name: Internal Medicine for Primary Care: Dermatology/Endocrinology/Oncology/Vascular.

• Organizer: Medical Education Resources (MER), a non-profit organization.

• Date: June 21-25, 2026.

• Location: Aulani, A Disney Resort & Spa in Oahu, HI.

2. Learning Objectives

Upon completion of this program, participants should be better able to:

• Develop patient-specific treatment plans for the management of type 2 diabetes.

• Diagnose and tailor treatment strategies for type 1 and type 2 diabetes.

• Identify the risks and benefits of utilizing bisphosphonates in the treatment of osteoporosis.

• Identify the risks of abnormal thyroid function.

• Describe the diagnostic evaluation of thyroid nodules with a focus on the utilization of ultrasound and cytology.

• Describe the spectrum of maladies included in peripheral vascular disease.

• Discuss presentation and interventional treatment of stroke patients.

• List current pharmacologic options for the management of aneurysms.

• Describe the evaluation and treatment of venous thrombosis.

• Discuss presentation and interventional treatment of swelling and ulcers of dysvascular limbs.

• Identify clinical practices shown to prevent cancer.

• Discuss the diagnostic approach to the patient with suspected cancer.

• Evaluate and manage risks of the cancer survivor.

• Describe the mechanism of action of new antiplatelet agents.

• Manage patients on new oral anticoagulants.

• Differentiate between the presentations and causes of atopic, contact (irritant and allergic), and nummular dermatitis.

• Identify cutaneous findings that serve as surrogates of internal diseases.

• Describe the step-wise approach for the diagnosis and treatment of acne and acneiform eruptions.

• Differentiate benign and malignant skin tumors and employ appropriate interoffice procedures.

• Detect pre-cancerous and cancerous skin lesions.

3. Target Audience

This program is targeted to office-based primary care providers and other health professionals with updates in primary care medicine. Best for internists, primary care physicians, dermatologists, endocrinologists, oncologists, and vascular medicine specialists.

4. Topics

Endocrinology

• Type 2 Diabetes Mellitus: Diagnosis and treatment; lessons from the DCCT; managing diabetic emergencies; screening; pre-diabetes.

• Insulin Therapy for Diabetes: Treating T2DM with insulin; T1DM.

• Osteoporosis: Review the epidemiology and pathophysiology of osteoporosis along with interpretation of DEXA scans and FRAX risk assessment; up-to-date therapeutic options.

• Disorders of Thyroid Function: Prevalence, diagnosis and treatment options of hypothyroidism and hyperthyroidism.

• Thyroid Nodules and Cancer: Diagnosis and treatment.

Vascular Medicine

• Peripheral Vascular Disease and Medical Therapy: Defining the spectrum of maladies under the umbrella of Peripheral Vascular Disease including the pathophysiology of atherosclerosis and treatments highlighting lipid lowering agents and antiplatelet therapy.

• Stroke: Initial Presentation to Medical and Surgical Treatment: An overview of embolic stroke including diagnosis and medical, surgical, and interventional therapy.

• Aortic and Peripheral Aneurysms: A guide for primary care outlining diagnosis, management, and therapeutic options.

• Management of Venous Thrombosis: A discussion focusing on the variety of venous thrombotic diagnoses and the multiple available treatment options.

• The Dysvascular Limb: How to Approach Swelling and Ulcers: An organizational approach to swelling and lower extremity ulceration focusing on the differential diagnosis, pathophysiology, and treatment.

Oncology

• Cancer Prevention: Cancer screening and clinical practices shown to prevent cancer will be reviewed.

• Approach to the Patient with Suspected Cancer: Symptoms, signs and diagnoses that raise the suspicion of cancer will be reviewed, and an approach to evaluating these patients will be presented.

• Management of Cancer Survivors: Medical issues related to cancer survivorship and approaches to surveillance for cancer recurrence will be reviewed.

• A Primary Care Review of New Antiplatelet Agents: Mechanisms of action, clinical indications, effectiveness, safety and peri-procedure management of current antiplatelet agents will be reviewed.

• A Primary Care Review of New Oral Anticoagulants: Mechanisms of action, clinical indications, therapeutic indices, perioperative management and approaches to reversal of new anticoagulant and antiplatelet medications will be reviewed.

Dermatology

• Dermatitis: Overview of the causes and forms of skin irritants; Contact, atopic, irritant, nummular, seborrheic and exfoliative; Treatment of blistering, oozing, crusting and flaking; Dagnostic principles and management strategies.

• Skin Manifestations of Systemic Disease: Skin will often reflect signs of systemic diseases, be useful for diagnosis, or suffer from a complication of disease or its treatment; Diagnosis of rheumatalogic, endocrine, gastrointestinal, and psychologic conditions based on cutaneous findings.

• Acne and Acneiform Eruptions: Identification of noninflammatory open or closed comedones and inflammatory lesions; Determination of treatment therapies based on acne grading scale; Bacterial folliculitis, drug-induced acne, hidradenitis suppurativa, miliaria, perioral dermatits, pseudofolliculitis barbae, rosacea, seborrheic dermatitis; Topical and systemic therapy.

• Benign Skin Tumors: Proper diagnosis and treatment of common benign tumors; Biopsies and histopathologic examination; Nevi, seborrheic keratosis keloids, hemangiomas and miscellaneous tumors; When to refer.

• Premalignant and Malignant Skin Tumors: Recognition of precursors of malignancies; Excisional and punch biopsies; Actinic keratosis, Bowen’s disease, squamous cell carcinoma, basal cell carcinoma, melanoma and other selected tumors; Risk reduction education.